Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Blood|November 8, 2003
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphomaNeil A Marshall, Linsey E Christie, Laura R Munro, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Facility volume and postoperative outcomes for malignant pleural mesothelioma: A National Cancer Data Base analysisVivek Verma, Christopher A Ahern, Christopher G Berlind, et al.
British Journal of Haematology|October 31, 2002
Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myelomaSharon Gordon, Miep H Helfrich, Hamdi I A Sati, et al.
Scientific Data|November 10, 2020
MFRED, 10 second interval real and reactive power for groups of 390 US apartments of varying size and vintageChristoph J Meinrenken, Noah Rauschkolb, Sanjmeet Abrol, et al.
Nature Chemistry|November 26, 2010
Storable, thermally activated, near-infrared chemiluminescent dyes and dye-stained microparticles for optical imagingJeffrey M Baumes, Jeremiah J Gassensmith, Jay Giblin, et al.
Clinical Lung Cancer|September 19, 2018
Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall SurvivalVivek Verma, Christopher A Ahern, Christopher G Berlind, et al.
Oncotarget|May 15, 2018
Combined linkage and association analysis of classical Hodgkin lymphomaAlastair Lawrie, Shuo Han, Amit Sud, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2017
National Cancer Database Report on Pneumonectomy Versus Lung-Sparing Surgery for Malignant Pleural MesotheliomaVivek Verma, Christopher A Ahern, Christopher G Berlind, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|August 22, 2002
The safety of reusing injectable collagen: a multicenter microbiological studyP J Culligan, S Koduri, M H Heit, et al.
The Annals of Thoracic Surgery|November 10, 2016
Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three YearsJoseph S Friedberg, Charles B Simone, Melissa J Culligan, et al.
Pageof 12